Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.

MLA

Sham, Jonathan G., et al. “Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 55, no. 5, May 2014, pp. 799–804. EBSCOhost, https://doi.org/10.2967/jnumed.113.132118.

APA

Sham, J. G., Kievit, F. M., Grierson, J. R., Miyaoka, R. S., Yeh, M. M., Zhang, M., Yeung, R. S., Minoshima, S., & Park, J. O. (2014). Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 55(5), 799–804. https://doi.org/10.2967/jnumed.113.132118

Chicago

Sham, Jonathan G, Forrest M Kievit, John R Grierson, Robert S Miyaoka, Matthew M Yeh, Miqin Zhang, Raymond S Yeung, Satoshi Minoshima, and James O Park. 2014. “Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 55 (5): 799–804. doi:10.2967/jnumed.113.132118.